5Schoevers RA,Van HL,Koppelmans V,et al.Managing the patientwith co-morbid depression and an anxiety disorder[J].Drugs,2008;68:1621-1634.
6沈渔村.精神病学:4版[M].北京:人民卫生出版社,2001.417-20.
7Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178(3):234-41
8Lenox-Smith A, Conway P, Knight C. Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK. Pharmacoeconomics 2004; 22(5): 311-9